Alaunos Therapeutics (TCRT) Gains from Investment Securities (2025)
Alaunos Therapeutics' (TCRT) quarterly Gains from Investment Securities came in at $31000.0 in Q2 2025.
Alaunos Therapeutics (TCRT) Gains from Investment Securities (2025) Analysis & Trends
Alaunos Therapeutics (TCRT) has 1 years of Gains from Investment Securities data on file, last reported at $31000.0 in Q2 2025.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $31000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $31000.0 (changed N/A YoY) and the FY2025 annual result came in at $31000.0, changed N/A from the prior year.
- Gains from Investment Securities was little changed at $31000.0 in Q2 2025.
- In the past five years, Gains from Investment Securities ranged from a high of $31000.0 in Q2 2025 to a low of $31000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |